APA (7th ed.) Citation

R, O., Y, R., & K, I. (2025). Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Cureus, 17(12), e99214. https://doi.org/10.7759/cureus.99214

Chicago Style (17th ed.) Citation

R, Ohta, Ryu Y, and Ichinose K. "Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis." Cureus 17, no. 12 (2025): e99214. https://doi.org/10.7759/cureus.99214.

MLA (9th ed.) Citation

R, Ohta, et al. "Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis." Cureus, vol. 17, no. 12, 2025, p. e99214, https://doi.org/10.7759/cureus.99214.